Excel Industries Ltd (EXCELINDUS) — FY26 Annual Report | 31 August 2026

Excel Industries Ltd reported a 12% revenue increase to ₹1,094.25 crores in FY25-26, driven by 11.8% net revenue growth and 26% export growth, with operating margin at 10.1%. Profit before tax declined 14% to [amount context mismatch] crores due to input cost pressures, though net cash position remained positive. The company advanced strategic initiatives including a 5-year contract manufacturing agreement generating ₹35-40 crores annually, biocide capacity expansion (commissioned Nov 2025), and a new R&D centre in Navi Mumbai (Oct 2025). Capex of ₹40 crores was deployed for contract manufacturing facilities, with ₹25 crores advance received from a customer. Renewable energy contributed 49% of electricity needs, while Scope 1 & 2 emissions intensity improved by 19.4%. Debt-equity ratio decreased to 0.65% from 1.04% due to reduced lease liabilities, and inventory turnover improved to 5.39. The company maintains backward integration in Yellow Phosphorous derivatives to mitigate import dependency, with China facing export controls. ESG commitments include Scope 3 emissions mapping, 100% health insurance coverage for employees, and CSR spending of ₹172.50 lakhs (exceeding ₹161.38 lakhs obligation). The Board approved director remuneration exceeding SEBI thresholds, and the AGM is scheduled for 24 September 2026 via VC/OAVM.